☰

Kirk D. Fowers, Ph.D. - Publications

Affiliations: 
2002 University of Utah, Salt Lake City, UT 
Area:
Biomedical Engineering, Pharmaceutical Chemistry, Immunology, Oncology
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Fowers KD, Kopeček J. Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates. Macromolecular Bioscience. 12: 502-14. PMID 22278817 DOI: 10.1002/Mabi.201100350  0.589
2001 Fowers KD, Callahan J, Byron P, Kopecek JI. Preparation of Fab' from murine IgG2a for thiol reactive conjugation. Journal of Drug Targeting. 9: 281-94. PMID 11697031 DOI: 10.3109/10611860108997936  0.489
2001 Fowers KD, Janatova J. Specific inhibition of C3 to facilitate general complement inhibition on endotoxin affinity sorbents for apheresis applications Biomaterials. 22: 1749-1761. PMID 11396878 DOI: 10.1016/S0142-9612(00)00335-5  0.314
2000 Tijerina M, Fowers KD, Kopecková P, Kopecek J. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Biomaterials. 21: 2203-10. PMID 10985494 DOI: 10.1016/S0142-9612(00)00161-7  0.39
1997 Fowers KD, Kopeček J. Development of a fibrinolytic surface: Specific and non-specific binding of plasminogen Colloids and Surfaces B: Biointerfaces. 9: 315-330. DOI: 10.1016/S0927-7765(97)00034-9  0.388
Show low-probability matches.